$7.92
-0.23-2.76%
al cierre: Nov 20, 4:00 PM EST
$7.92
N/A
After hour: 4:01 PM EST

Benitec Biopharma (BNTC) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q1 | Nov 13, 2026 | $-0.26 | $-0.29 | 10.3 % |
| Q4 | Sep 14, 2026 | $-0.26 | $-0.26 | 0.00 % |
| Q3 | May 14, 2026 | $-0.24 | $-0.27 | 11.1 % |
| Q2 | Feb 12, 2026 | $-0.26 | $-0.23 | -13.0 % |
Quarterly Revenue (Billions)
| Metric | Q1 '27 | Q4 '26 | Q3 '26 | Q2 '26 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.29 | $-0.26 | $-0.27 | $-0.23 |
| Actual | $-0.26 | $-0.26 | $-0.24 | $-0.26 |
| Surprise | +10.3% | 0.00% | +11.1% | -13.0% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q2 '27E | Q3 '27E | Q4 '27E | Q1 '28E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.30 | $-0.32 | $-0.36 | $-0.41 |
| Revenue | ||||
| Consensus | — | — | — | — |